Christopher Robinson/LinkedIn
Jun 13, 2026, 14:29
Christopher Robinson: SNRI vs SSRI and the Risk of Hypertensive Disorders of Pregnancy
Christopher Robinson, Associate Professor Maternal Fetal Medicine at University of South Carolina, shared a post on LinkedIn:
“Serotonin-norepinephrine reuptake inhibitors vs selective serotonin reuptake inhibitors and the risk of hypertensive disorders of pregnancy”
Title: Serotonin-norepinephrine reuptake inhibitors vs selective serotonin reuptake inhibitors and the risk of hypertensive disorders of pregnancy
Authors: Anick Bérard, Yves Mufike Lumu, Gabra Nohmie, Narimene Ait Belkacem
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jul 19, 2026, 05:52Join the Global Conversation on Reproductive Medicine! – ESHRE
-
Jul 19, 2026, 05:51Mays Aladham: Inspiring How ESHRE Gathers Us Every Year From Across the Globe on One Platform!
-
Jul 19, 2026, 05:48Strengthening Primary Care Partnerships Through Clinical Education – City Fertility
-
Jul 19, 2026, 05:47Marco Zaccaria: 3 Essential Steps to Manage Uterine Fibroids!
-
Jul 19, 2026, 05:45PGT-A Integration Into PGT-M Protocols in Young ART-Naïve Patients – RBMO
-
Jul 19, 2026, 05:41ELTA 90 MG Explores the Future of IVF at ESHRE 2026 – Elta 90 Medical Genetics
-
Jul 18, 2026, 07:55Ahmed Fahim Hemaid: Starting New Role as Consultant Obstetrician and Gynaecologist at Great Western Hospital
-
Jul 18, 2026, 07:52Suganya Venkat: How the 2002 Hormone Therapy Study Changed Menopause Care
-
Jul 18, 2026, 07:50Paras Yadav: Why Uterine Aging Matters in Fertility and IVF Outcomes?